Ginkgo Bioworks Holdings Inc’s recently made public that its Officer Che Austin acquired Company’s shares for reported $970.0 on Dec 06 ’24. In the deal valued at $9.80 per share,99 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Coen Steven P. sold 330 shares, generating $3,183 in total proceeds. Upon selling the shares at $9.64, the insider now owns 6,869 shares.
Before that, Dmytruk Mark E. sold 741 shares. Ginkgo Bioworks Holdings Inc shares valued at $7,146 were divested by the insider at a price of $9.64 per share. As a result of the transaction, Dmytruk Mark E. now holds 32,386 shares, worth roughly $0.38 million.
BTIG Research downgraded its Ginkgo Bioworks Holdings Inc [DNA] rating to a Sell from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including William Blair’s analysts, who decreased its forecast for the stock in early May from “a Mkt perform” to “an Underperform”. Raymond James also remained covering DNA and has decreased its forecast on November 14, 2023 with a “Mkt perform” recommendation from previously “an Outperform” rating. BTIG Research revised its rating on November 09, 2023. It rated DNA as “a Neutral” which previously was an “a Buy”.
Price Performance Review of DNA
On Friday, Ginkgo Bioworks Holdings Inc [NYSE:DNA] saw its stock jump 20.58% to $11.66. Over the last five days, the stock has gained 34.02%. Ginkgo Bioworks Holdings Inc shares have fallen nearly -82.75% since the year began. Nevertheless, the stocks have fallen -77.58% over the past one year. While a 52-week high of $75.20 was reached on 01/02/24, a 52-week low of $5.26 was recorded on 09/10/24. SMA at 50 days reached $8.16, while 200 days put it at $20.62.
Levels Of Support And Resistance For DNA Stock
The 24-hour chart illustrates a support level at 10.33, which if violated will result in even more drops to 9.00. On the upside, there is a resistance level at 12.46. A further resistance level may holdings at 13.26. The Relative Strength Index (RSI) on the 14-day chart is 71.99, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.22, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 4.62%. Stochastics %K at 91.90% indicates the stock is a selling.
How much short interest is there in Ginkgo Bioworks Holdings Inc?
A steep rise in short interest was recorded in Ginkgo Bioworks Holdings Inc stocks on 2024-11-15, dropping by -0.56 million shares to a total of 7.32 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 7.88 million shares. There was a decline of -7.7%, which implies that there is a negative sentiment for the stock.
